Menu Back to DIA-2015-51st-Annual-Meeting-Develop-Innovate-Advance

Overview

DIA 2015 51st Annual Meeting: Develop.  Innovate.  Advance.

The DIA 2015 51st Annual Meeting brings together a global community of life sciences professionals at all levels and across all disciplines all with a common goal to foster innovation that will lead to the development of safe and effective medical products and therapies to patients.

The DIA Annual Meeting provides the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.

Who should attend?

The DIA Annual Meeting is designed for individuals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, and related medical products.

Learning objectives

  • Provide a global unbiased platform to raise the level of discussion to facilitate innovation that will change the future of health care
  • Provide comprehensive coverage of the full development and life cycle management of process for all health care products
  • Offer a holistic and integrated approach to the development life cycle management of regulated health care products

Program Committee

  • Christopher P. Austin, MD
    Representative Invited National Institutes of Health (NIH), United States
  • Michael  Rosenblatt, MD
    Representative Invited Merck & Co., Inc., United States
  • J. Lynn  Bass, PharmD, RPh
    Representative Invited Jazz Pharmaceuticals, United States
  • Daniel M. Bollag, PhD
    Representative Invited Ariad Pharmaceuticals Inc., United States
  • Linda F. Bowen, MS, RAC
    Representative Invited Sanofi, United States
  • Jonca C. Bull, MD
    Representative Invited FDA, United States
  • Bill  Byrom, PhD
    Representative Invited ICON plc, United Kingdom
  • Joy A. Cavagnaro, PhD, RAC
    Representative Invited Access BIO, United States
  • Karla  Childers, MS
    Representative Invited Johnson & Johnson, United States
  • Leah  Christl, PhD
    Representative Invited FDA, United States
  • Betsy  Fallen, RN
    Representative Invited Safe-Biopharma Association, United States
  • Ron D. Fitzmartin, PhD, MBA
    Representative Invited FDA, United States
  • Michael  Folkendt, MS
    Representative Invited FDA, United States
  • Elizabeth E. Garrard, PharmD
    Representative Invited Clinipace Worldwide, United States
  • Jonathan  Haddad, MPH, MT
    Representative Invited GlaxoSmithKline, United States
  • Martin  Harvey Allchurch, LLM
    Representative Invited European Medicines Agency, European Union , United Kingdom
  • Jonathan Solomon Helfgott, MS
    Representative Invited Johns Hopkins University, United States
  • Deborah J. Henderson, MSN
    Representative Invited Merck & Co., Inc., United States
  • Rima  Izem, PhD
    Representative Invited FDA, United States
  • Janet  Jenkins-Showalter
    Representative Invited Genentech, A Member of the Roche Group, United States
  • John  Kamp, JD, PhD
    Representative Invited Coalition For Healthcare Communication, United States
  • Ellen  Kelso
    Representative Invited Chesapeake IRB, United States
  • Lisa Palladino Kim, MS
    Representative Invited Rutgers, The State University of New Jersey, United States
  • Lynn  King, MHA
    Representative Invited TKL Research, Inc., United States
  • Agnes V. Klein, DrPH, MD
    Representative Invited Health Canada, Canada
  • Stephen  Knowles, MD, MRCP
    Representative Invited Eli Lilly and Company, United States
  • Mark A. Kryah, PMP
    Representative Invited Eli Lilly and Company, United States
  • JeanMarie  Markham
    Representative Invited Clinlogix LLC, United States
  • Philomena  McArthur, JD
    Representative Invited Johnson & Johnson International, United States
  • Ann  Meeker-O'Connell, MS
    Representative Invited Johnson & Johnson, United States
  • Jon  Meyer, MBA, MSc
    Representative Invited Life Science Strategy Group, LLC, United States
  • Mary Stober Murray, MBA
    Representative Invited Bristol-Myers Squibb Company, United States
  • Bob  Muzerall
    Representative Invited AMPLEXOR Life Sciences, LLC, United States
  • Nancy Bradish Myers, JD
    Representative Invited Catalyst Healthcare Consulting, Inc, United States
  • Jane E. Myles, MS
    Representative Invited Genentech, A Member of the Roche Group, United States
  • Roger  Nosal, MA, MS
    Representative Invited Pfizer Inc , United States
  • Pradip  Paul, MD, MS
    Representative Invited Strategic Pharmacovigilance and Risk Management, United States
  • Kirsten H. Paulson, MS, RAC
    Representative Invited Pfizer Inc, United States
  • Julia  Petses, PharmD
    Representative Invited Sanofi US, United States
  • Christine  Pierre, RN
    Representative Invited Society for Clinical Research Sites, United States
  • James E. Polli, PhD
    Representative Invited University of Maryland School of Pharmacy, United States
  • Sarah  Pope Miksinski, PhD
    Representative Invited FDA, United States
  • Badri  Rengarajan, MD
    Representative Invited Actelion, United States
  • Matthew D. Rotelli, PhD
    Representative Invited Eli Lilly and Company, United States
  • Leslie M. Sam
    Representative Invited Eli Lilly and Company, United States
  • Abdul J. Sankoh, PhD, MA, MS
    Representative Invited FORUM Pharmaceuticals, United States
  • Suzanne  Sensabaugh, MBA, MS
    Representative Invited HartmannWillner LLC, United States
  • Ashley F. Slagle, PhD, MS
    Representative Invited Aspen Consulting, LLC, United States
  • Nancy  Smerkanich
    Representative Invited University of Southern California, United States
  • Maureen  Smith
    Representative Invited Canadian Organization For Rare Disorders (CORD), Canada
  • William B Smith, MD
    Representative Invited New Orleans Center for Clinical Research, United States
  • Ling  Su, PhD
    Representative Invited Lilly Asia Ventures, China
  • Sameer  Thapar, PharmD
    Representative Invited Rutgers, The State University of New Jersey, United States
  • Toshiyoshi  Tominaga, PhD
    Representative Invited Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Linda Fossati Wood, MPH, RN
    Representative Invited MedWrite, Inc., United States
Load More

Contact us

DIA Americas
800 Enterprise Road, Suite 200
Horsham, PA 19044-3595, USA
Phone: +1 215 442 6100
Fax: +1 215 442 6199
Email: dia@diaglobal.org

Questions related to the DIA 2015 51st Annual Meeting Program? Contact: annualmeetingprogram@diaglobal.org

Ways to register

Registration override should work.